Chemours vs Ingevity
Chemours spun out of DuPont carrying both high-value fluoroproducts businesses and legacy environmental liabilities that continue to weigh on its balance sheet, while Ingevity extracts specialty chemicals from crude tall oil and activated carbon products that serve a narrower but highly defensible set of markets. Both are specialty chemical companies where product mix and liability management define the investment case. The Chemours vs Ingevity comparison examines free cash flow generation, litigation risk, leverage, and which company's operational profile offers the cleaner path to shareholder returns.
Chemours spun out of DuPont carrying both high-value fluoroproducts businesses and legacy environmental liabilities that continue to weigh on its balance sheet, while Ingevity extracts specialty chemi...
Investment Analysis
Chemours
CC
Pros
- Strong demand for Opteon™ refrigerant products supports operational performance despite challenging macroeconomic conditions.
- Attractive valuation with discount cash flow analysis suggesting the stock is undervalued by approximately 33%, offering potential value for long-term investors.
- Analyst consensus rates Chemours as a 'Buy' with an average price target implying a potential 35% upside from current levels.
Considerations
- Q3 2025 earnings significantly missed estimates, with EPS of $0.20 versus $0.26 expected, highlighting near-term profitability challenges.
- Ongoing environmental litigation and leadership changes introduce uncertainty and have contributed to a 40% stock decline over the past year.
- Net income remains negative with reported losses, reflecting continued operational and financial headwinds despite revenue generation.
Ingevity
NGVT
Pros
- Diverse operations spanning specialty chemicals, advanced polymer technologies, and automotive carbon products provide multiple growth avenues.
- Primary revenue generation from North America markets supports operational stability in a large and developed economy.
- Solid balance sheet metrics including a current ratio of 2.00 indicate good short-term liquidity management.
Considerations
- Relatively low quick ratio of 0.69 signals potential challenges in meeting immediate liabilities without inventory sales.
- Negative interest coverage ratio suggests challenges in covering interest expenses, indicating leveraged financial structure.
- Smaller market capitalization and valuation multiples reflect limited scale and potential growth constraints compared to larger peers.
Buy CC or NGVT in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
